Regeneron/Sanofi’s PD-1 drug candidate; Zika targeting drugs and vaccines developments; CMO of Achillion will leave this month; Lincoln’s anti-malarial drug
Dec 19, 2017
Regeneron/Sanofi’s PD-1 drug candidate will be tested with ISA’s HPV immunotherapy Regeneron and Sanofi’s PD-1 candidate cemiplimab is paired with Dutch biotech ISA P...
Read MoreGlobal atrial fibrillation market is expected to grow to $12.5 billion by 2020
May 12, 2016
Global AF market was $7.2 billion in 2015 and expected to grow to $12.5 billion by 2020 with and compound annual growth rate (CAGR) of 11.62%. There are four NOACs which ar...
Read MoreGlobal VTE market is expected to grow to $4.75 billion by 2020
May 11, 2016
Venous Thromboembolism- Market Insights & Drugs Sales Forecast (VTE) -2020: New Report by DelveInsight suggests that the Global VTE market was $4.2 billion in 2015 and ...
Read MoreAnticoagulants-Market Insights; Drugs Sales Forecast (VTE & AF)
May 10, 2016
According to DelveInsight researchers, the Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 202...
Read MorePancreatic Cancer Market Insights, Epidemiology and Market Forecast-2020
Mar 21, 2016
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing co...
Read MoreNon-Hodgkin’s Lymphoma (NHL) – Market Insights, Epidemiology and Market Forecast-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing co...
Read MoreNonalcoholic Steatohepatitis (NASH) – Market Insights, Epidemiology and Market Forecast-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing co...
Read MoreIdiopathic pulmonary fibrosis (IPF) – Market Insights, Epidemiology and Market Forecast-2020
Mar 18, 2016
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing co...
Read MoreAcute Myeloid Leukemia- Market Insights, Epidemiology & Forecast
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing co...
Read MoreRheumatoid Arthritis Market, Epidemiology and Market Forecast-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing co...
Read MoreIndication-Market Insights, Epidemiology and Market Forecast,2010-2020:DelveInsight’s New Launch
Feb 23, 2016
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing co...
Read MorePD-1 and PD-L 1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016
Feb 8, 2016
DelveInsight has made strong presence in Oncology market with 100+ Reports on Oncology based Indications & Mechanism of Action (MOA). DelveInsight Report, PD-1 an...
Read MoreLAG-3 Antagonists, TIM-3 Antagonists; OX40 Agonists- Pipeline Insights, 2016 – A DelveInsight Report
Jan 21, 2016
DelveInsight, the leading market research and consulting company has added new report “LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists- Pipeline Insights, 2016â€...
Read MoreChimeric Antigen Receptor T cell Immunotherapy Market Analysis and Forecast
DelveInsight, the leading market research and consulting company has added new report “Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Land...
Read MoreEmergence of Stem cells and its Market Impact
Apr 17, 2015
Big Pharma Guiding the Stem Cells Future Stem cells (SCs) have been an excitement area of medical research since 1800s. In the mid 1800s it was discovered that cells were b...
Read More
